Business
‘Robust immune responses’: Oxford virus trial offers hope for elderly – The New Daily
Oxford University-AstraZeneca’s coronavirus vaccine has produced a robust immune response in elderly people, according to early test results.
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca says.
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.
The Financial Times reported the vaccine, being developed by Oxford and AstraZeneca,…
-
General16 hours agoElon Musk deletes post claiming Donald Trump is ‘in the Epstein files’
-
General15 hours agoVance downplays row between Trump, ’emotional guy’ Musk
-
Noosa News11 hours agoElectrify your vehicle, home or business at Noosa’s EV & Electrify Everything Expo
-
General22 hours agoLabor’s communism must be destroyed